A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT06386419 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Dyslipidemia

Interventions

DRUG: inclisiran

Sponsor

Novartis Pharmaceuticals